CA9 and liver cancer: In this study, we employed a combination of in silico molecular docking and in vitro cell validation experiments to identify three ferroptosis suppressor genes, AR, HIF1A, and CA9, as promising components of a survival prognosis model during the metformin‐induced ferroptosis process in liver cancer.